Literature DB >> 26623126

Underrated value of repeated right heart catheterization in pulmonary hypertension with heart failure-a case of persisted pulmonary arterial hypertension after treatment for biventricular failure.

Shinhee Park1, Hee Young Yoon1, Soomin Jeung1, Nah Kyum Lee1, Min-Seok Kim1, Jung-Min Ahn1, Dae-Hee Kim1, Jae Seung Lee1.   

Abstract

Pulmonary hypertension (PH) is a common complication of left heart disease and its presence in patients with heart failure predicts worse clinical outcomes. Specific agents targeting pulmonary arterial hypertension (PAH) have been developed over the last few years, but the efficacy of these agents in pulmonary hypertension due to left heart disease (PH-LHD) is uncertain. We report a case of idiopathic pulmonary arterial hypertension (IPAH) initially presented with biventricular failure, which was misdiagnosed as PH-LHD. A 31-year-old man who had a history of recurrent hemoptysis was referred to our center with biventricular failure. Right heart catheterization (RHC) showed elevated mean pulmonary arterial pressure (mPAP) and pulmonary capillary wedge pressure (PCWP). He was diagnosed as having PH-LHD, specifically combined post-capillary and precapillary PH (CpcPH). We treated him for 2 years with diuretics, a beta blocker, an angiotensin-converting enzyme (ACE) inhibitor, and sildenafil, which was added to treat CpcPH. A follow-up echocardiography showed that biventricular function had improved, but not PH. A second RHC revealed elevated mPAP and normal PCWP, which made us change the diagnosis to IPAH. In conclusion, it is important to perform repeated RHC in CpcPH patients after the improvement of left heart dysfunction to distinguish CpcPH from IPAH.

Entities:  

Keywords:  Cardiac catheterization; heart failure; idiopathic pulmonary arterial hypertension (IPAH); pulmonary hypertension (PH)

Year:  2015        PMID: 26623126      PMCID: PMC4635302          DOI: 10.3978/j.issn.2072-1439.2015.10.09

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  11 in total

1.  PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.

Authors:  Marco Guazzi; Marco Vicenzi; Ross Arena; Maurizio D Guazzi
Journal:  Circ Heart Fail       Date:  2010-10-29       Impact factor: 8.790

2.  Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.

Authors:  Micah R Fisher; Paul R Forfia; Elzbieta Chamera; Traci Housten-Harris; Hunter C Champion; Reda E Girgis; Mary C Corretti; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2009-01-22       Impact factor: 21.405

3.  Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study.

Authors:  Milton Packer; John McMurray; Barry M Massie; Abraham Caspi; Vincent Charlon; Alain Cohen-Solal; Wolfgang Kiowski; William Kostuk; Henry Krum; Barry Levine; Paolo Rizzon; Jordi Soler; Karl Swedberg; Susan Anderson; David L Demets
Journal:  J Card Fail       Date:  2005-02       Impact factor: 5.712

Review 4.  Endothelin receptor antagonists for pulmonary arterial hypertension.

Authors:  Chao Liu; Junmin Chen; Yanqiu Gao; Bao Deng; Kunshen Liu
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 5.  World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation.

Authors:  James C Fang; Teresa DeMarco; Michael M Givertz; Barry A Borlaug; Gregory D Lewis; J Eduardo Rame; Mardi Gomberg-Maitland; Srinivas Murali; Robert P Frantz; Dana McGlothlin; Evelyn M Horn; Raymond L Benza
Journal:  J Heart Lung Transplant       Date:  2012-09       Impact factor: 10.247

6.  Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.

Authors:  Gregory D Lewis; Ravi Shah; Khurram Shahzad; Janice M Camuso; Paul P Pappagianopoulos; Judy Hung; Ahmed Tawakol; Robert E Gerszten; David M Systrom; Kenneth D Bloch; Marc J Semigran
Journal:  Circulation       Date:  2007-09-04       Impact factor: 29.690

Review 7.  WHO's in second?: A practical review of World Health Organization group 2 pulmonary hypertension.

Authors:  Sif Hansdottir; Dayna J Groskreutz; Brian K Gehlbach
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

8.  Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort.

Authors:  Geoff Strange; David Playford; Simon Stewart; Jenny A Deague; Helen Nelson; Aaron Kent; Eli Gabbay
Journal:  Heart       Date:  2012-07-03       Impact factor: 5.994

9.  Poor agreement between pulmonary capillary wedge pressure and left ventricular end-diastolic pressure in a veteran population.

Authors:  Abbas Bitar; Mona Selej; Islam Bolad; Tim Lahm
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

10.  Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry.

Authors:  Andrew J Swift; Smitha Rajaram; Judith Hurdman; Catherine Hill; Christine Davies; Tom W Sproson; Allison C Morton; Dave Capener; Charlie Elliot; Robin Condliffe; Jim M Wild; David G Kiely
Journal:  JACC Cardiovasc Imaging       Date:  2013-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.